Abstract
Vitiligo was recognized long ago under different names. Firstly, the Ebers Papyrus (circa 1500 BC) mentions two types of diseases affecting the colour of the skin, one being probably leprosy and the other vitiligo. In the ancient Vedic scripture of India (circa 1400 BC), Sanskrit words “kilas” and “svitra” (white patches on the skin) can be found. The early classics of the Far East (1200 BC) mention “shirabito” (white man). The Hebrew word “Zoorat” in the bible corresponds to a group of achromic diseases including vitiligo. “Baras and alabras” were the Arabic names used to describe vitiligo. The term “vitiligo” itself was introduced in the first century of our era. The confusion of leprosy with vitiligo in the Old Testament under “Zoorat” is an important cause for the social stigma attached to white spots on the skin. Detailed and effective treatments for vitiligo are found in different sacred books. The modern photochemotherapy is an improvement of a photochemotherapy practised in the ancient world with herbals containing furocoumarins (mainly Ammi majus Linnaeus, Psoralea corylifolia) and sun. In the mid-1960s the synthetic furocoumarin (trioxsalen and trimethylpsoralen) were developed. The effectiveness of PUVA (psoralen + UVA) for the treatment of some patients with vitiligo was confirmed during 1974–1982. More recently, narrowband UVB therapy, local microphototherapy, excimer laser, topical treatments with corticosteroids and calcineurin inhibitors and melanocyte transplantation have been successively introduced.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Goldman L, Richard S, Moraites R. White spots in Biblical Times. Arch Dermatol. 1966;93:744–53.
Ortonne JP, Mosher DP, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. New York, NY: Plenum medical school; 1983. p. 129–32.
Ebbel B. The papyrus Ebers. Copenhagen: Levin and Munksgaard; 1963.
Donata SR, Kesavan M, Austin SR. Clinical trial of certain Ayurveda medicines indicated in vitiligo. Ancient Sci Life. 1990;4:202–6.
Nair BK. Vitiligo: a retrospect. Int J Dermatol. 1978;17:755–7.
Panda AK. The medicohistorical perspective of vitiligo. Bull Ind Hist Med. 2005;25:41–6.
Ben Achour T. TafsirAt Tahir Wat-Tanwir. Edn Dar SahouneHannadi, city, 1973.
Olsson M, Juhlin M. Leucoderma treated by transplantation of a basal cell layer enriched suspension. Br J Dermatol. 1998;138:644–8.
Prasad PV, Bhatnagar VK. Medico-historical study of “Kilasa” (vitiligo/leucoderma) a common skin disorder. Bull Ind Inst Hist Med. 2003;33:113–27.
Harris JL, Lerner AB. Amino acid sequence of alpha-melanocyte stimulating hormone. Nature. 1957;179:1346–7.
Fahmy IR, Abn-Shady H. Pharmacological study and isolation of crystalline constituents: Amoïdin. Quart J Pharm and Pharmacol. 1947;20:281–6.
Pathak M, Daniels F, Fitzpatrick TB. The presently known distribution of furocoumarins (psoralens) in plants. J Invest Dermatol. 1962;39:225–39.
Kuske H. Experimentelle untershungersur Photosensibiliste der Haut durch pflanzliche Wisrktoffe. Arch F Dermatol et Syphil. 1938;178:112–4.
El Mofty AM. A preliminary clinical report on the treatment of leukodermias with Ammi Majus Linn. J Roy Egypt. 1948;31:651–6.
Lerner AB, McGuire JS. Vitiligo and sympathectomy: the effect of sympathectomy and alpha-melanocyte stimulating hormone. Arch Dermatol. 1966;94:269–78.
Lim HW, Grimes PE, Agbai O, et al. Afamelanotide and narrowband UVB phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015;151(1):42–50.
Pathak M, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA) 2000BC to 1992 AD. J Photochem Photobiol. 1992;14:3–22.
Lotti TM, Menchini G, Andreassi L. UV-B radiation microphototherapy. An elective treatment for segmental vitiligo. J Eur Acad Dermatol Venereol. 1999;12:102–8.
Behl PN. Treatment of vitiligo with homologous thin Thiersch skin grafts. Curr Med Pract. 1964;8:218–21.
Falabella R. Epidermal grafting: an original technique and its application in achromic areas. Arch Dermatol. 1971;104:592–600.
Falabella R. Repigmentation of leucoderma by autologous epidermal grafting. J Dermatol Surg Oncol. 1984;10:136–44.
Falabella R, Escobar C, Borrero L. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol. 1992;262(1):230–6.
Gauthier Y, Surleve-Bazeille JE. Autologous grafting with non cultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol. 1992;26:191–4.
Olsson M, Juhlin M. Melanocyte transplantation in vitiligo. Lancet. 1992;34(8825):981.
Mac Neil S, Eves P. Simplifying the delivery of cultured melanocytes. In: Gupta S, Olsson MJ, Kanwar A, editors. Surgical management of vitiligo. Oxford: Blackwell; 2007. p. 191–201.
Singh C, Parsad D, Kanwar AJ, Dogras AS, Kumar R. Comparison between autologous non cultured extracted hair follicle outer root sheath cell suspension and autologous non cultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. Br J Dermatol. 2013;169(2):287–93.
Vanscheidt W, Hunziker T. Repigmentation by outer-root sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Dermatology. 2009;218(4):342–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gauthier, Y., Benzekri, L. (2019). Historical Aspects of Vitiligo. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)